Drug Warning (Accutane)

Warning About Suicide to go on Acne Medicine

Published in Medical Letter on the CDC and FDA, March 16th, 1998

Makers of a popular prescription acne medication said they would add a warning to the label telling doctors to look out for depression and suicidal tendencies in their patients.

The U.S. Food and Drug Administration (FDA) and Hoffmann-La Roche, Nutley, New Jersey, said they had received reports of depression and suicide in teenagers taking Accutane, its prescription product for severe acne.

"Although the Accutane label already included information regarding depression as a possible adverse reaction, the agency felt healthcare providers and others needed additional information as a result of severe adverse event reports the agency has received," the...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (1998-03-16)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry